Medidata Solutions Inc. (NASDAQ:MDSO) shares hit a new 52-week high during trading on Friday . The stock traded as high as $55.25 and last traded at $54.56, with a volume of 109,914 shares traded. The stock had previously closed at $53.99.

Several brokerages recently commented on MDSO. Wells Fargo & Co. cut shares of Medidata Solutions from an “outperform” rating to a “market perform” rating in a report on Thursday, July 21st. KeyCorp restated a “buy” rating and set a $55.00 target price on shares of Medidata Solutions in a report on Sunday, May 22nd. Jefferies Group cut shares of Medidata Solutions from a “hold” rating to an “underperform” rating and increased their target price for the stock from $35.00 to $36.00 in a report on Tuesday, April 26th. Leerink Swann began coverage on shares of Medidata Solutions in a report on Tuesday, April 26th. They set a “market perform” rating and a $47.00 target price for the company. Finally, Zacks Investment Research cut shares of Medidata Solutions from a “buy” rating to a “hold” rating in a report on Wednesday, July 13th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the stock. The company has an average rating of “Buy” and an average target price of $51.70.

The company has a market capitalization of $3.00 billion and a P/E ratio of 139.36. The stock has a 50 day moving average price of $48.96 and a 200-day moving average price of $42.61.

Medidata Solutions (NASDAQ:MDSO) last released its quarterly earnings data on Wednesday, July 20th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. The company earned $114.60 million during the quarter, compared to the consensus estimate of $112.39 million. The business’s revenue was up 16.8% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.22 EPS. On average, equities analysts forecast that Medidata Solutions Inc. will post $1.01 earnings per share for the current year.

In other Medidata Solutions news, EVP Eileen Schloss sold 2,083 shares of the business’s stock in a transaction on Friday, July 29th. The shares were sold at an average price of $53.04, for a total transaction of $110,482.32. Following the completion of the sale, the executive vice president now owns 29,013 shares in the company, valued at approximately $1,538,849.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, President Vries Glen Michael De sold 32,500 shares of the business’s stock in a transaction on Tuesday, July 12th. The shares were sold at an average price of $49.25, for a total transaction of $1,600,625.00. Following the sale, the president now owns 1,015,153 shares of the company’s stock, valued at approximately $49,996,285.25. The disclosure for this sale can be found here.

A number of hedge funds have made changes to their positions in MDSO. Bank of Montreal Can raised its stake in shares of Medidata Solutions by 96.6% in the fourth quarter. Bank of Montreal Can now owns 33,760 shares of the company’s stock worth $1,664,000 after buying an additional 16,587 shares during the period. State of Tennessee Treasury Department acquired a new stake in shares of Medidata Solutions during the fourth quarter worth approximately $2,124,000. Mutual of America Capital Management LLC raised its stake in shares of Medidata Solutions by 0.6% in the fourth quarter. Mutual of America Capital Management LLC now owns 57,900 shares of the company’s stock worth $2,854,000 after buying an additional 345 shares during the period. Rhumbline Advisers raised its stake in shares of Medidata Solutions by 9.4% in the fourth quarter. Rhumbline Advisers now owns 68,254 shares of the company’s stock worth $3,364,000 after buying an additional 5,855 shares during the period. Finally, Principal Financial Group Inc. raised its stake in shares of Medidata Solutions by 3.5% in the fourth quarter. Principal Financial Group Inc. now owns 372,108 shares of the company’s stock worth $18,341,000 after buying an additional 12,610 shares during the period.

Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Medidata Clinical Cloud provides a platform of technology and data analytics solutions designed to manage activities across clinical development.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.